A

ADC Therapeutics SA
D

ADCT

1.17000
USD
-0.06
(-4.88%)
Market Closed
Volume
35,442
EPS
-1
Div Yield
-
P/E
-1
Market Cap
148,813,655
Overview
Related Instruments
CIEN
CIEN
D
390.68
-16.90(-4.15%)
CSCO
CSCO
D
114.165
1.405(1.25%)
113.710-0.455(-0.40%)
ERIC
ERIC
D
9.33500
0.03000(0.32%)
HPE
HPE
D
47.725
0.075(0.16%)
47.650-0.075(-0.16%)
INTC
INTC
D
92.310
-7.920(-7.90%)
91.540-0.770(-0.83%)
JCI
JCI
D
143.440
0.120(0.08%)
NOK
NOK
D
9.06500
-0.66500(-6.83%)
8.97000-0.09500(-1.05%)
TMUS
TMUS
D
180.080
9.620(5.64%)
180.190+0.110(+0.06%)
VZ
VZ
D
46.420
2.580(5.89%)
46.240-0.180(-0.39%)
More

Title: ADC Therapeutics SA

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more linesof systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.